Imatinib Recruiting Phase 3 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03515018Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients
NCT02326311Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response